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The frontiers of bioimaging are currently being pushed toward the integration and
correlation of several modalities to tackle biomedical research questions holistically
and across multiple scales. Correlated Multimodal Imaging (CMI) gathers information
about exactly the same specimen with two or more complementary modalities that—in
combination—create a composite and complementary view of the sample (including
insights into structure, function, dynamics and molecular composition). CMI allows to
describe biomedical processes within their overall spatio-temporal context and gain a
mechanistic understanding of cells, tissues, diseases or organisms by untangling their
molecular mechanisms within their native environment. The two best-established CMI
implementations for small animals and model organisms are hardware-fused platforms
in preclinical imaging (Hybrid Imaging) and Correlated Light and Electron Microscopy
(CLEM) in biological imaging. Although the merits of Preclinical Hybrid Imaging (PHI)
and CLEM are well-established, both approaches would benefit from standardization
of protocols, ontologies and data handling, and the development of optimized and
advanced implementations. Specifically, CMI pipelines that aim at bridging preclinical
and biological imaging beyond CLEM and PHI are rare but bear great potential to
substantially advance both bioimaging and biomedical research. CMI faces three main
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challenges for its routine use in biomedical research: (1) Sample handling and preparation
procedures that are compatible across modalities without compromising data quality,
(2) soft- and hardware solutions to relocate the same region of interest (ROI) after
transfer between imaging platforms including fiducial markers, and (3) automated
software solutions to correlate complex, multiscale, multimodal and volumetric image
data including reconstruction, segmentation and visualization. This review goes beyond
preclinical imaging and puts accessible information into a broader imaging context. We
present a comprehensive overview of the field of CMI from preclinical hybrid imaging
to correlative microscopy, highlight requirements for optimization and standardization,
present a synopsis of current solutions to challenges of the field and focus on current
efforts to bridge the gap between preclinical and biological imaging (from small animals
down to single cells and molecules). The review is in line with major European initiatives,
such as COMULIS (CA17121), a COST Action to promote and foster Correlated
Multimodal Imaging in Life Sciences.
Keywords: bioimaging, correlated multimodal imaging, CMI, COMULIS, CLEM, correlative microscopy, hybrid
imaging, correlation software
INTRODUCTION
The ideal imaging setup would provide both (i) holistic and (ii)
multiscale information about the same sample:
Holistic imaging refers to probing all relevant information
spaces for the same sample, assessing both structural and
functional information (Figure 1). Functional imaging allows
to portray dynamic physiological, metabolic and biological
processes within the sample, such as diffusion, perfusion or
glucose uptake. This requires both sensitivity to low molecular
concentrations and specificity, the number of potential molecules
resolved per scan (Figure 2). Since these processes occur
in a complex tissue environment, ideally, this information
is acquired in-vivo or in a close-to-native context without
damaging the sample by irradiation. This requires trade-offs in
bioimaging using single modalities since usually either structural
or functional information is gathered by a single modality,
and high-resolution localization with protein or ultrastructural
accuracy often requires sectioning the sample and prevents in-
vivo studies.
Multiscale structural imaging visualizes the same sample
across all relevant scales. Ideally, it combines high axial and
Abbreviations: AFM, Atomic Force Microscopy; CARS, Coherent Anti-Stokes
Raman Spectroscopy; CLEM, Correlative Light and Electron Microscopy;
CMI, Correlated Multimodal Imaging; CT, Computed Tomography; EM,
Electron Microscopy; FIB, Focused Ion Beam; FM, Fluorescence Microscopy;
HREM, High Resolution Episcopic Microscopy; LM, Light Microscopy;LSFM,
Light Sheet Fluorescence Microscopy; MPI, Magnetic Particle Imaging; MPM,
MultiPhoton Microscopy; MRI, Magnetic Resonance Imaging; MSI, Mass Spec
Imaging; OCT, Optical Coherence Tomography; OI, Optical Imaging; PAI,
Photoacoustic Imaging; PET, Positron Emission Tomography; PHI, Preclinical
Hybrid Imaging; RS, Raman Spectroscopy; SEM, Scanning Electron Microscopy;
SHG, Second Harmonic Generation Microscopy; SPECT, Single Photon Emission
Computed Tomography; Superresolution, Superresolution Microscopy (such as
STORM, PALM, STED); SXT, Soft X-ray Tomography; TEM, Transmission
Electron Microscopy; TPEF, Two-Photon Excited Fluorescence Microscopy;
US, Ultrasound.
lateral resolution with high penetration depths, and is able to
image or scan a wide field of view in a reasonable time that allows
the correlation of complementary parameters acquired across
the entire sample. However, bioimaging is usually performed
using single modalities, which restricts multiscale imaging: Either
a large field of view is imaged at low magnification, which
provides overview and tissue context but restricts localization,
or the specimen is imaged at high resolution, which provides
(sub)cellular insights but limits contextual information. Besides,
penetration depth comes at the expense of lateral resolution
(Figure 3) and is limited due to aberration and attenuation by
scattering and absorption (with highly wavelength-dependent
elastic (Rayleigh) scattering—the intensity of Rayleigh-scattered
light is I ∝ 1/λ4), and hence restricts 3D in-vivo imaging. The
achievable penetration depth is proportional to the scattering
mean free path, and strongly depends on the composition of
the biological tissue, such as the presence and organization of
microvasculature or collagen [2].
No single modality can gain multiscale or holistic information
and accurately and comprehensively decipher the inner
working of cells or entire organisms. Only the combination
and—importantly—the multimodal correlation of imaging
technologies allow to overcome the limitations mentioned above
by integrating the best features of the combined techniques
(compare Tables 1, 2, 3). Correlated Multimodal Imaging
(CMI) gathers information about the specimen with two or
more complementary modalities that—in combination—create
a composite view of the sample. It is a holistic multiscale
approach that spans the entire resolution range from nano- to
millimeters, and provides complementary information about
structure, function, dynamics, and molecular composition of
the sample. CMI can hence study biomedical processes within
their overall spatio-temporal context, and mechanistically
analyze pathologies, diseases and organisms down to the
underlying molecular events. Correlative Light and Electron
Microscopy (CLEM), as a well-established case of CMI, can for
Frontiers in Physics | www.frontiersin.org 2 April 2020 | Volume 8 | Article 47
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FIGURE 1 | Holistic imaging accessing all relevant information spaces from structural to functional imaging. Representation for the modalities mentioned in the text:
SXT, Soft X-ray Tomography; HREM, High Resolution Episcopic Microscopy; EM, Electron Microscopy; CT, Computed Tomography; OI, Optical Imaging including
bioluminescence and fluorescence imaging; LSFM, Light Sheet Fluorescence Microscopy; MPM, MultiPhoton Microscopy, Confocal, Confocal Microscopy; MRI,
Magnetic Resonance Imaging; Ultrasound, PAI, Photoacoustic Imaging; OCT, Optical Coherence Tomography; AFM, Atomic Force Microscopy; MSI, Mass Spec
Imaging; Superresolution, Microscopy such as STORM, PALM, STED; PET/SPECT, Positron Emission Tomography/Single Photon Emission Computed Tomography.
example gather both spatial (Electron Microscopy, EM) and
functional information about a specific molecule (Fluorescence
Microscopy, FM) within its subcellular context, and achieve near-
atomic resolution (EM) within a relatively broad field of view
(FM). Additionally, due to its complementarity and different
contrast mechanisms, CMI allows to validate quantifications and
conclusions drawn from any single modality.
For this review, we solely focus and distinguish between
preclinical (imaging small animals and molecular processes
in-vivo) and biological imaging (largely microscopy, ex-vivo
visualization of subcellular processes and molecules, cells or
tissues of model organisms). So far, CMI approaches in biological
and preclinical research mainly focus on the correlation of two
modalities [3]. There is one well-established example for each
field: (1) Hardware-fused platforms for Hybrid Imaging [4]
in preclinical research and diagnostics (which we refer to as
Preclinical Hybrid Imaging, PHI), and (2) Correlative Light
and ElectronMicroscopy (CLEM) in biological research [5]. The
most prominent (and commercially available) implementations
surely are micro-Positron Emission Tomography and micro-
Computed Tomography (PET/CT) and Single Photon Emission
Tomography (SPECT)/CT, but there is a large variety of other
CMI combinations both in preclinical research and correlative
microscopy which will broaden the accessible biomedical
information significantly. The field of CMI is highly dynamic
and heading toward more complex integrated implementations
of multimodal workflows that also include advanced non-
commercial setups, such as Soft X-Ray Tomography in biological
imaging. Currently, however, there are only very few strategies
that aim at bridging biological and preclinical imaging—even
though these Novel CMI Pipelines reap the full potential
of this approach in tackling biomedical research questions
mechanistically. In this context, data handling and Correlation
Software for diverse imaging data sets play a crucial role in CMI.
While the benefits of PHI and CLEM are more and more
recognized in biomedical research, they lack gold standards
for protocols or data handling and limit quantification. This
includes for example the quantification of the correlation
accuracy in CLEM or biomedical imaging ontologies. Apart
from standardization, both PHI and CLEM leave room for
optimization and the integration of advanced setups, such
volume or super-resolution CLEM [6, 7] or hybrid preclinical
multimodal platforms for Optical Coherence Tomography
(OCT), Photoacoustic Imaging (PAI), and non-linear in-vivo
Frontiers in Physics | www.frontiersin.org 3 April 2020 | Volume 8 | Article 47
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microscopy [8]. For the routine implementation of CMI in
biomedical research, several common bottlenecks need to be
overcome, such as sample handling and preparation procedures
that are compatible across modalities without compromising
data quality, soft- and hardware solutions to relocate the same
region of interest (ROI) after transfer between imaging platforms
including fiducial markers, and automated software solutions to
FIGURE 2 | Functional imaging—sensitivity vs. specificity. Same abbreviations
as in Figure 1. Adapted from Pogue et al. [1], with permission from the
American Journal of Roentgenology (copyright owner).
correlate complex, multiscale, multimodal and volumetric image
data including reconstruction, segmentation and visualization.
Due to these challenges and lack of gold standards, availability
of CMI in routine biomedical research is limited. Specifically
for novel CMI pipelines, the involved cutting-edge imaging
technologies can be expensive and time-consuming—and simply
not available to a single researcher. They require a broad range
of interdisciplinary expertise across different imaging modalities
from sample preparation to image processing. Besides, it is
difficult for the user to keep track of the constantly expanding
range of available modalities and their strengths and limitations.
The use of CMI in biomedical research is also restricted by
the lack of readily accessible commercial solutions that allow
to address biomedical research questions without substantial
technological R&D.
CMI will play a crucial role in the future of bioimaging
and in life sciences, which is reflected by major European
initiatives, such as the European Society for Hybrid Imaging or
COMULIS, an EU-funded COST network that aims fostering
CMI, disseminating its benefits, and accelerating its technological
implementation as a versatile tool in biomedical research by
addressing the mentioned challenges and bottlenecks.
STATE-OF-THE-ART
CLEM and Correlative Microscopy
Ever since the first analysis of a biological sample using EM by
Porter et al. [9], the light microscope was used first to target
the cell of interest. This highlights one of the hallmarks of
the power of CLEM: The identification of a specific event to
FIGURE 3 | Structural multiscale imaging. Penetration depth usually comes at the expense of lateral resolution. Same abbreviations as in Figure 1.




































TABLE 1 | Imaging parameters, advantages and limitations of the most used in-vivo preclinical imaging techniques.
Modality CT MRI US PET SPECT MPI OI
Contrast mechanism X-ray attenuation of
tissues
















Penetration >500mm >500mm 10–150mm >500mm >500mm >500mm 1–10 mm
Intrinsic contrast High (bone)
Low (soft tissues)


















Spatial resolution ≤100µm ≤100µm 30–800µm 1–2mm 0.5–2mm 1mm 1 mm
Sensitivity (Imaging
agent)
mM µM—pM n.a. pM pM-nM pM nM
Typical acquisition time 10–25min 5–60min 5–15min 10–90min 30–90min 1–2min 2–10 min
Advantages - excellent bone
imaging
- non-ionizing radiation











- fully quantitative data














- fully quantitative data







Limitations - radiation dose









- difficult to quantitate
















- low spatial resolution
- semi-quantitativedata























CT, Computed Tomography; MRI, Magnetic Resonance Imaging; US, Ultrasound; PET, Positron Emission Tomography; SPECT, Single Photon Emission Computed Tomography; MPI, Magnetic Particle Imaging; OI, Optical Imaging
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TABLE 2 | Imaging parameters, advantages and limitations of the most used in-vivo microscopy techniques in preclinical research.
Modality OCT RS MPM (CARS, TPEF, SHG) PAI
Contrast
mechanism














Penetration ∼1–2mm ∼0.5mm ∼0.5mm ∼10 mm
Axial resolution ≥0.5µm (light source
dependent)
≥0.3µm (diffraction limited) ≥0.3µm (diffraction limited) ∼80µm (implementation
dependent)
Lateral resolution ≥1µm (diffraction limited) ≥1µm (diffraction limited) ≥1µm (diffraction limited) ∼40µm (photoacoustic wave)
Frame rate 3D/1Hz 2D/1–10 s/point 2D/<10Hz 3D/<10 mHz
ROI 10 × 10 mm2 1–100 µm2 0.5 × 0.5 mm2 10 × 10 mm2





- quantitative blood flow






- endogenous and exogenous
contrast














OCT, Optical Coherence Tomography; RS, Raman Spectroscopy; MPM, MultiPhoton Microscopy; CARS, Coherent Anti-Stokes Raman Spectroscopy; TPEF, Two-Photon Excited
Fluorescence Microscopy; SHG, Second Harmonic Generation Imaging; PAI, Photoacoustic Imaging.
be analyzed at higher resolution in the electron microscope.
Since then, CLEM has been applied to answer specific biological
questions, most notably the seminal work by Rieder, using
(live) Differential Interference Contrast (DIC) light microscopy
to study microtubule organization during cell division [10].
CLEM took off shortly after the groundbreaking use of Green
Fluorescent Protein (GFP) [11] that transformed life science
research. The groups of Polishchuk et al. [12, 13] used the
expression of GFP tagged to a viral protein (VSV-G) to
first study the movement of post-Golgi transport carriers and
subsequently analyze that exact same carrier at high resolution
in EM. This workflow nicely exemplified that by combining
the power of each technique, the sum is greater than its parts
(1+1= 3, [14]). Live imaging by FM provided the history of
the carrier (originating from the Golgi) and EM not only
showed the ultrastructure of the carrier but in addition provided
information about its surrounding environment as a bonus,
the so-called reference space. One of the great advantages
of this workflow is its relative simplicity. It makes use of
an imaging dish with a finder pattern embossed in it. The
pattern can be recorded in the light microscope (LM) and
as the finder pattern stands out from the rest of the glass
coverslip, the pattern is also transferred to the resin block.
This allows for trimming down the sample to only a very few
cells around the cell of interest [15]. In principle, any lab with
a light and an electron microscope will be able to perform
this technique.
There are many different approaches to a CLEM experiment
given the diversity of EM (TEM, SEM, electron tomography)
and FM techniques (LSFM, MPM, super-resolution, confocal),
which can be roughly classified in chemical fixation and
embedding (in-resin) approaches, and cryo approaches (see
e.g. Table 3). We have compiled a large number of those
in a series of three books in the Methods in Cell Biology
series (Volume 111, 124, and 140). Of particular interest for
routine use is the preservation of in-resin fluorescence. This
method retains the fluorescence (of GFP) after high pressure
freezing and freeze substitution to Lowicryl [16–18]. So, after
sectioning first, the fluorescence can be recorded with high Z-
resolution because the section is only 70–100 nm thick and
then can be mapped with high precision (50 nm) onto the
underlying ultrastructure. An interesting development here
is the integrated light and electron microscope that would
allow for even better and more direct correlation as discussed
later. It is important to highlight that the development of
each of those techniques is driven by the need to answer
a biological question and it should always be the case that
this biological question is driving what kind of technology
will be applied. As an example, we have been studying the
formation of membrane tubules emanating from endosomes
that transport and recycle cargo back to the plasma membrane.
Chemical fixation as done by the pre-embedment approach
described earlier [15] causes the tubules to fragment into
smaller carriers, thus destroying the very object of study [19].
Hence a cryo-fixation method had to be developed that allows
for capturing events observed live in the fluorescence light
microscope on a time scale of seconds to be observed down
the electron microscopy. This resulted in the development of
the EMPACT2 + RTS with Leica Microsystems and allowed
us and others to capture short-lived cellular events for study
at the ultrastructural level [19–21]. Apart from CLEM, other
well-established examples of correlative microscopy include the




































TABLE 3 | Imaging parameters, advantages, and limitations of the most used ex-vivo microscopy techniques in biological research.




Deflection of the cantilever is
converted into force or lateral
and vertical position.
Contrast: e.g., spring constant
of cantilever
Electrons interact with the
sample. Heavy atoms
deviate electrons more from
their path and generate
contrast. Heavy metals are
generally used to enhance
contrast in biological
samples










excited by lasers and emit
at a longer wavelength
Contrast: e.g., quantum
efficiency of fluorophore
LSFM scans a thin slice of
the sample—optical
sectioning—using a plane of
light instead of a point
The sample is illuminated
with ’water window’ X-rays
(2.3–4.4 nm), which are
absorbed 10 times more
strongly by
carbon-containing
biomolecules than by water
(Beer-Lambert Law)
Penetration Not specified: Material and AFM
tip dependent (< 20µm)
<1µm Technology dependent:
∼10µm
<100µm ≥1 cm <20µm (material
dependent)
Axial resolution <1 nm >2 nm Technology dependent:
>100 nm
≥0.4µm ≥0.4µm ∼ 50–20 nm







ROI <100 × 100 µm2 <10 × 10 µm2 Technology dependent:
∼50 × 50 µm2
∼0.2–1 mm2 ∼0.2–1 mm2 (limitation is
the production of a uniform,
thin light sheet over the
volume)
∼15 × 15 µm2
Advantages - very high lateral and axial
information






- reference space in relation
to structure of interest
- very high resolution






- fast data collection
- Live imaging
- less photo damage to
sample (longer imaging)





- Niche technique between
FM & EM
Limitations - acquires mainly near surface
information
- no real time imaging




- no real time imaging
- applicable to nearly
immobile molecules
- mostly not very suited for
live imaging




- Special holders, limited
specimen exchange
- Access to synchrotron
radiation
- Molecular context missing
- no live imaging
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combination of FM and AFM. Besides, the combination of Soft
X-ray Tomography (SXT) with FM and its super-resolution
implementations allows to correlate two complementary contrast
mechanisms at similar spatial resolution, and was used to
study cell infections or the molecular distributions within the
ultrastructural architecture [22, 23].
Advanced super-resolution FM circumvents the diffraction
barrier with spatial resolution below 200 nm and has become
a powerful tool for the observation of specific molecules
in living cells, tissues, and even whole organisms. It is a
valuable tool to study bio-molecular dynamics, interactions
and co-localization via selective and specific labeling of certain
components within cells and to provide biological information
at the nanoscale by measuring forces of interacting objects.
However, even with the recent implementation of high-speed
AFM, the temporal resolution of fluorescence-based techniques
cannot be reached. Likewise, the introduction of super-resolution
microscopy cannot reach the spatial resolution of AFM.
However, the combination of “Force-and-Light” allows to watch
and simultaneously manipulate or control individual molecules.
These two techniques in combination allow probing fundamental
biological processes at a previously unrepresented level. In
general, it is possible to combine all parameters gained from
AFM techniques with those of FM ones (Figure 4). Nevertheless,
it needs to be considered which combinations yield meaningful
insights into the investigated system, and more importantly,
which combinations do not influence each other—such as
measuring of interaction forces and interaction kinetics as the
kinetics will be directly altered by an applied force. Moreover,
synchronized operations of both techniques instead of sequential
ones are limited by the individual mechanical stability of each
technique (e.g., thermal drift, acoustic disturbance, mechanical,
and electronic noise/vibration).
To date, various combinations have been successfully
confirmed to characterize previously inaccessible biological
information. For example, the AFM tip was used as a nanopipette
to supply targeted molecules to bio-membranes and its temporal
interaction was described using FM [24, 25]. This approach
allows for a so-called touch-and-watch experiment to study the
uptake of foreign or active substances for example. Besides,
there are a variety of correlative applications, which assessed
combinations of the properties depicted in Figure 4: (i) Elasticity
and diffusion using for example Förster Resonance Energy
Transfer (FRET) between dye molecule [26–30]; (ii) interaction
forces and diffusion using single molecule force spectroscopy
and Total Internal Reflection Microscopy (TIRF), termed Single
Molecule Cut and Paste, to assemble/split nucleotide-based
aptamers individually [25, 31, 32]; (iii) interaction forces and
localization using super-resolution FM to resolve the architecture
of focal adhesion under physiological relevant conditions
[33, 34]; and manipulation and localization to assemble single
molecules patterns via the AFM to identify blinking parameters
and maximal resolvable fluorophore density [35, 36].
Preclinical Hybrid Imaging
Preclinical imaging of small laboratory animals covers all
clinically used methods for human in-vivo imaging and also
several methods that have not been implemented to humans yet.
In-vivo imaging consists of anatomical (structural) imaging and
molecular (functional) imaging.
Anatomical Imaging of body structures utilizes X-rays
(CT—Computed Tomography), magnetic properties of tissues
(MRI—Magnetic Resonance Imaging) or interacting of tissues
with sound/pressure waves (US—ultrasonography or ultrasound
imaging). CT images correspond to differential attenuation of
X-rays depending on the density of interacting structures. CT
images are characterized by very good spatial resolution but low
contrast—so they are used preferentially for imaging of hard
structures (bones). MRI imaging is based on nuclear magnetic
resonance of hydrogen nuclei (protons) in oscillating magnetic
fields. MRI provides inferior spatial resolution compared to
CT but excellent soft tissue resolution [37]. Ultrasound waves
penetrate soft tissues and form echoes on the boundary of tissues
with different acoustic impedance. This allows for imaging of
soft tissues such as muscle, tendon, veins, and inner organs.
Higher frequency waves (40 to 70 MHz) penetrate little into the
tissue (10–15mm) but provide excellent spatial resolution down
to 30µm. US imaging is generally 2D but can be acquired and
computed to form a 3D and 4D data set [38].
Molecular Imaging localizes a position of accumulated
molecules (contrast agents). All three anatomical in-vivo
techniques can be enhanced to molecular imaging by the use
of contrast agents. Even without the use of contrast agents,
MRI can track changes in blood flow and oxygenation of brain
tissue connected to increased brain activity after stimulus and
thus reveal the brain regions activated by such stimulus [39].
Ultrasound Doppler imaging can also detect functional changes
in blood flow without contrast application.
Other pure molecular in-vivo imaging methods utilize
radioisotopic, magnetic, optical or optoacoustic contrasts. The
obtained images only show regions of contrast accumulation
and must be co-registered with anatomical images to validate
the exact position of the signal in the body, i.e. always require
correlative or hybrid imaging approaches. Radioisotopic imaging
methods include PET and SPECT. PET data acquisition is based
on positron-emitting radioisotopes, in which the positron travels
a short distance in the surrounding tissue, then annihilates
with an electron forming a pair of high energy photons (511
keV), which travel in opposite directions and are detected by
a ring of detectors surrounding the object of interest. The
coincident signals are recorded and the position of radioisotopic
contrast lays on the connecting line of the two detected photons.
The mean distance of the emission and annihilation positions
(positron range) is dependent on the energy of the PET isotope
and the attenuation properties of the surrounding tissue [40].
In contrast to PET, SPECT imaging is based on single photon
emitting isotopes that are detected by a gamma camera. To
determine the direction from where the photon traveled, the
collimator (typically made out of lead or tungsten) with single
or multiple pinholes or slits must be placed between the imaged
object and detector. Only photons that pass the collimator are
detected. Based on the trajectory between the collimator and
the detector, the position of annihilation can be reconstructed.
SPECT isotope energies typically range between 30 and 300 keV
Frontiers in Physics | www.frontiersin.org 8 April 2020 | Volume 8 | Article 47
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FIGURE 4 | Sketch of properties gained from AFM (upper row) and FM-based (lower row) techniques. Gray arrows depict possible combinations of properties. In
general, we can differentiate acquired information premised on AFM, whether they are generated via force spectroscopy (measurement of interaction forces via
functionalized tips or elasticity via ball-bearing tips) or by spatial scanning (sample texture or feature manipulation depending on the applied force) of the sample
(yellow). In contrast, FM-based techniques study movement (e.g., diffusion) and interaction kinetics of molecules, and localize these particles down to an accuracy of
a few nanometers depending on the number of detected photons.
and allow multi-isotope imaging when utilizing isotopes with
no overlapping energy windows. SPECT and PET imaging have
intrinsically different properties in terms of sensitivity and spatial
resolution. While in SPECT, the collimator design vastly limits
the number of detected photons and hence the sensitivity, PET
imaging does not need a collimator and moreover, benefits from
the ring design of detectors around the object of interest since
the two photons are detected concomitantly by two detectors
opposing the site of annihilation. Hence, sensitivity in PET
is superior to SPECT sensitivity. Spatial resolution in PET,
however, is limited by positron range and crystal size, whereas
in SPECT, since the photon originates directly from the nucleus,
spatial resolution is theoretically superior to PET resolution.
However, spatial resolution and sensitivity are dependent on
multiple factors, such as choice of isotope, crystal material,
utilized detectors, etc. and especially in SPECT, collimator choice
must be adapted based on the desired application. In order to
diminish the effects of ionizing radiation, radioisotopes with
short half-lives are used for PET and/or SPECT imaging. PET
and SPECT scanners are usually constructed as hybrid devices
(PET/CT, SPECT/CT, or PET/SPECT/CT). Recently, new PET
detector materials compatible with magnetic resonance allowed
the construction of PET/MRI hybrid scanners. The advantage
of such scanners is excellent soft tissue contrast for precise
localization of signal within organs, and the absence of CT
imaging allows to diminish the radiation dose accumulated in
imaged objects.
Magnetic properties of contrast agents are the basis for
magnetic particle imaging (MPI) and electron paramagnetic
resonance (EPR) imaging. MPI measures the position of
superparamagnetic nanoparticles by detecting their non-linear
magnetization response to oscillating magnetic fields [41]. The
method ensures positive contrast localization with high spatial
and temporal resolution. EPR imaging is similar to nuclear
magnetic resonance; electron spins are affected instead of atomic
nuclei spins. Different excitation frequencies are used compared
to MRI (mostly in the microwave range). Absolute oxygen levels,
reactive oxygen species (ROS), oxidative stress or spin probes can
be determined in vivo by this method [42]. Magnetic molecular
methods are usually co-registered with MRI or CT [43].
Optical imaging (OI) is fast and relatively cheap imaging of
fluorescence and/or luminescence signals. Fluorescent probes are
excited bymatching wavelengths and emit fluorescent signal. The
limitation of the method is the low light penetration through
the tissues. The measured signal is thus not quantitative with
more light loss for deeper probe localization. As hemoglobin
(oxy- and deoxy-) absorbs the light in wavelengths below 650 nm,
the optimal imaging window opens in the near-infrared (NIR)
region (650–1,350 nm). Water absorbs at longer wavelengths
[44]. Luminescence based on cellular expression of luciferase
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enzymes converting substrates to visible light gives superior
images because it avoids illumination and corresponding tissue
autofluorescence [45]. Fluorescent images are co-registered to
hybrid images using brightfield or X-ray anatomical imaging.
While OI was initially limited to 2D imaging, several technologies
have been developed in recent years which allow 3D tomographic
imaging in combination with morphological imaging based on
CT. For preclinical OI, firefly luciferase is the most commonly
used transgene allowing longitudinal studies on e.g., promoter
activity in transgenic mice, growth and dissemination of
implanted tumors [46] or biodistribution and proliferation of
organisms in infection models [47]. Kuo et al. published the
first tomographic imaging setup for luciferase imaging, termed
diffuse luminescence imaging tomography (DLIT) [48]. Such
systems are now also available with built-in CT capability,
where CT data are used to determine surface topology. When
implanting luciferase labeled tumor cells, this technology allows
proper signal allocation to organs when combined with CT
contrast agents. NIR fluorescence imaging (NIR) is not only
applied in preclinical but also in clinical applications, e.g., for
image guided surgery [49]. For the absorption range of 700–
900 nm, several fluorophores, nanoprobes and reporter genes
have been developed. Another emerging area in OI is the use of
the so-called second NIR window (NIR-II) ranging from 1,000
to 1,700 nm [50]. This wavelength range enables imaging with
improved tissue penetration depth and spatial resolution, but
also minimized tissue autofluorescence and reduced scattering.
Correlative imaging of NIR fluorescence and CT is enabled
by applying fluorescence molecular tomography imaging (FMT,
[51]). Using a commercialized system, tomographic imaging
is achieved by acquiring multiple fluorescence images from
different positions in transmission mode.
Another molecular imaging method is photoacoustic imaging
(PAI). The laser NIR pulses penetrate into the tissue and
deliver energy to photoacoustic contrast molecules which
undergo a thermoelastic expansion [52]. This expansion then
generates ultrasound waves detected by the ultrasound probe.
There are specific endogenous contrasts (oxyhemoglobin,
deoxyhemoglobin, melanin) and exogenously delivered
photoacoustic contrasts for labeling of cells, vasculature,
tumors etc. The contrasts give specific positive signal on the
ultrasonic background. While other preclinical molecular
imaging methods have a spatial resolution around 1mm,
photoacoustic imaging can produce images with a resolution of
50µm or less. Nevertheless, the method is limited by the effective
light penetration about 10mm in soft tissues.
While CT has traditionally been used to assess morphologies
in bone tissue, it holds more potential to the field of correlative
imaging. Going beyond the depiction of mineralized tissues, it
provides 3D reference volumes in integrated PET/CT, SPECT/CT
or OI/CT devices that readily provide registered, multimodal
data sets. Furthermore, CT can be used in a post-mortem,
high-resolution, soft-tissue approach. Vascular structures can be
visualized at high resolution in 3D via contrast agent perfusion
[53], and contrast-enhanced microfocus CT (CE-CT) allows
for simultaneous visualization of bone and soft tissues [54].
This makes CT a potent tool for both (a) integrated in-vivo
applications providing longitudinal, registered 3D volumes in
limited resolution and contrast, and (b) high-resolution post-
mortem imaging with soft tissue contrast for 3D anatomical and
pathological correlation.
Another important multimodal imaging approach that is
gaining importance in preclinical settings as it preserves the
tissue is label-free (optical) imaging and non-invasive, aseptic
assessment of tissues and cells in-vivo at high resolution.
While FM relies on specific contrast or the application of
dyes or fluorescent proteins to highlight certain structures,
most molecules do not exhibit intrinsic contrast and the
application of dyes or fluorescent proteins might interfere with
function and is typically limited to three to four colors due
to spectral overlap, which makes it difficult to discriminate
between the labeled structures or cells. Especially, optical
coherence tomography (OCT) has matured over the last three
decades to a potent non-invasive, high-resolution, label-free
interferometric optical diagnostic imaging modality enabling
video-rate in vivo cross-sectional tomographic visualization
of structures with resolution comparable to histopathology,
serving as in vivo optical biopsy [55, 56]. Despite the large
potential of OCT, sensitivity and specificity to detect pathologic
tissue is restricted and the correlation with other techniques
is required. Raman spectroscopy (RS) complements OCT by
giving a quantitative measure of the full molecular fingerprint
of biomolecules such as lipids, proteins, carbohydrates, and
nucleic acids, but is intrinsically slow. It relies on the effect of
inelastic scattering of photons, stimulating molecular vibrations
providing specific information on the chemical composition
and molecular structure, and is an emerging technique in
life sciences owing to its unique capability of generating
spectroscopic fingerprints of cells and tissues in a non-
destructive and label-free approach. It has been demonstrated
that the combination OCT/RS on cancerous tissue can increase
diagnostic sensitivity, specificity and accuracy compared to
a single modality [57]. Two-photon excited fluorescence
(TPEF) microscopy can be used to visualize endogenous
fluorophores such as NADH and FAD giving information
about redox states. Additionally, second harmonic generation
(SHG) imaging is well-suited to image collagen fibers. Since
SHG signals arise from induced polarization rather than from
absorption, this leads to significantly reduced photobleaching
and phototoxicity compared to fluorescence methods. SHG
microscopy in combination with TPEF microscopy can monitor
collagen structure changes and cellular metabolic activity in vivo
during wound healing [58]. Hybrid multimodal multiphoton
microscopy (MPM) [59] with single-photon sensitivity and
submicron spatial resolution using the response of endogenous
chemical biomarkers in skin, such as collagen or lipids acts as
fast and label-free in vivo optical biopsy [60]. The synergistically
combination of OCT with nonlinear optical imaging techniques
such as TPEF, SHG, and CARS (Coherent Anti-Stokes Raman
Spectroscopy) provides access to detailed information of tissue
structure and molecular composition in a fast, label-free and
non-invasive manner [61]. MPM offers high axial resolution
with molecular contrast but limited speed and penetration depth.
Combining MPM with OCT [62] adds wide-field morphologic
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information to the chemical fingerprint [63]. As described above,
PAI can overcome penetration and scanning range limits of
OCT, allowing imaging of deep vasculature [64, 65]. PAI can
monitor angiogenesis, map blood oxygenation with sub-100µm
resolution and centimeter penetration depth. In combination
with OCT it adds valuable vascular information in depth to the
ultrahigh-resolution images [66, 67].
The combination of these optical modalities not only
overcomes the limitations of isolated, standard imaging
approaches, but also provides unique and complementary
information (see Tables 1, 2) which is only achievable through
the correlation of these data.
Novel CMI Pipelines
Since CMI allows to gain structural, functional, dynamical and
chemical information about a single sample for a well-defined
time point or even time lapse series across all relevant length
scales and levels of biological organization, it is the most suitable
approach to gain otherwise inaccessible insights into a huge
variety of intricate biological processes and understand them
within their complex (micro)environment. So far, common CMI
approaches mainly focus on the combination of two modalities
with two prevalent examples in biological imaging (CLEM) and
preclinical research (PHI) that allow to combine functional with
structural information from a singular event or within a single
study (see Introduction). In PHI, two complementary imaging
modalities are fused within a single setup, such as PET/CT or
PET/MRI. PHI serves as a valuable diagnostic and research tool
that can uncover molecular processes and biochemical pathways
in living animals non-invasively within their anatomy, and has
been used to study wide variety of biomedical questions, for
example in cancer biology or brain research [68]. CLEM has
become the method of choice to analyze rare and specific
processes within tissues or cell lines, and has been used to
study a wide variety of biological questions including membrane
trafficking and viral pathways [17]. The maturity of the two
fields is reflected in several commercial implementations for PHI
(e.g., PET/CT or SPECT/CT), and a first commercially available
integrated fluorescence and scanning electron microscope and
commercial tools, ancillary equipment and software for CLEM
to facilitate re-locating of the region of interest across modalities
(see section State-of-the-Art). As illustrated in section State-
of-the-Art, the limits of CLEM and PHI are currently pushed
towards developing advanced implementation. For CLEM, these
efforts include for example advanced FM approaches, such as
(cryo)super-resolution or FM of thick tissues [6, 7]. Apart from
CLEM, more and more other dual-modality combinations of
microscopy technologies have been established during the last
decade. Examples of these setups include various combinations
of AFM with (advanced) FM (cp. section CLEM and Correlative
Microscopy); combinations of soft X-ray tomography (SXT) and
FM, for example to localize proteins involved in mitochondrial
fission within their close-to-native subcellular context [22,
34, 69]; the correlation of mass spectrometry-based imaging
(MSI) with EM to combine the inherently lower-resolution
chemical images obtained from secondary ionmass spectrometry
(SIMS) with the high-resolution ultrastructural images from
EM [70]; and the combination of SIMS [71] and matrix-
assisted laser desorption/ionization MSI (MALDI MSI) [72]
with fluorescence in-situ hybridization (FISH) to link microbial
phylogeny to metabolic activity at the single-cell level. Also,
the newly developing field of molecular histology has to be
mentioned that incorporates findings from MADLI MSI or
infrared spectroscopy (IR) in classical histomorphology [73].
Besides, an increasing interest has arisen in research focused on
elemental and molecular information that play crucial roles in
both physiological and pathological metabolic processes. MALDI
MSI was combined with laser-ablation inductively coupled
plasma MS (LAICP MS) to study lipid changes colocalized with
platinum, sulfur or phosphor distributions [74], and SIMS data
were combined with topographical information from AFM to
record accurate chemical 3D maps [75]. Advanced PHI includes
R&D setups and pipelines that showcase combinations of in-vivo
OI, OCT/PAI, US, MRI, CT, or PET [8, 76]. Examples as outlined
in section Preclinical Hybrid Imaging include label-free imaging
using OCT and RS [57], or the combination of MRI and OI [77].
Novel CMI pipelines go beyond correlative microscopy and
PHI setups and usually include more than two complementary
modalities. They aim at (1) bridging (preclinical) in-vivo imaging
with ex-vivo biological microscopy to zoom in from a living
sample to individual cellular structures and/or (2) adding
localized spectroscopic [biophysical (e.g., mechanical properties
or vibrational modes) or chemical (e.g., molecular or elemental)]
information to the acquired structural and functional parameters.
With all the electromagnetic spectrum explored for imaging,
only incremental improvements in contrast, resolution, or
sensitivity are expected for the available spectrum of imaging
technologies (see e.g. Tables 1–3). To explore the multiple spatial
and temporal scales necessary for a holistic understanding of
organisms and their biology, novel CMI pipelines will be the
method of choice. However, novel CMI pipelines with more than
two modalities are in their infancy due to lack of access to a
single researcher, the broad expertise required to oversee several
modalities and due to lacking workflows and software solutions
to track ROIs across modalities from living 3D tissue down to
high lateral molecular resolution. While there are several EU-
funded initiatives that aim at improving accessibility of advanced
imaging technologies and interdisciplinary imaging expertise
(such as Euro-BioImaging or COMULIS), such novel CMI
pipelines nevertheless require substantial method development.
Due to the diverse plethora of potential combinations of imaging
technologies, setting up universal correlation protocols for CMI
pipelines is not feasible. Sample preparation procedures for ex-
vivo microscopy differ substantially across the technologies and
even within a modality; AFM images alone, for example, can
be acquired under various conditions (vacuum, atmosphere, and
liquid). Correlative imaging usually requires modality-specific
preparation and setup trade-offs, such as between preservation
of fluorescence and subcellular architecture for CLEM, between
the AFM laser and excitation spectra of the used fluorophores
to avoid bleaching for correlative AFM [78], or between
preservation of fluorescence and X-ray contrast for correlative
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CT. Dependent on the used technology, the sample preparation
needs to be adapted.
In respect to correlation strategies, universal protocols to
assess correlation accuracy are not implemented and restrict
finding the same ROI after relocation between imaging platforms
or co-alignment of data sets. Strategies to improve correlation
of different technologies include (1) resolution matching of the
technologies and (2) correlative markers that can be visualized in
different imaging technologies.
A common approach to improving correlation accuracy in
correlative microscopy is to match the FM resolution to that of
the microscopy technique with the highest resolution (EM, SXT,
AFM) by integrating super-resolution FM. For CMI pipelines
that bridge in-vivo with ex-vivo imaging, usually intermediate
(mesoscopic) resolution steps need to be implemented—as
for example mesoscopic ex-vivo MRI for the integration of
macroscopic in-vivo MRI data and microscopic CT data [79].
A common example includes the emerging use of CT in a
different context: As an intermediate imaging technology to
create a 3D template of the sample after in-vivo imaging
and before sectioning of the sample to probe the ROI. CT
can visualize thick tissues in 3D at micrometer resolution,
tracks distortions and morphological changes of the ROI after
embedding and fixation, and allows ROI identification even
without (preserving) fluorescence. CT is specifically suited as an
intermediate technology between in-vivo optical microscopy and
EM since it can also visualize the sample in resin blocks due to the
heavy-metal stains used for EM sample preparation. It qualifies
for other correlative microscopy approaches as well since it
can reveal endogenous landmarks, such as the vasculature, after
barium sulfate perfusion.
While there are a variety of fiducial markers that can be used
and tracked in correlative microscopy (such as QDs or dye-
labeled nanoparticles), there are currently no correlative markers
that can be visualized with high accuracy both bymicroscopy and
preclinical imaging technologies. Besides, robust fiducial markers
that might withstand electron bombardment or high X-ray doses
are also lacking. A common approach to facilitate correlation
when using CT as an intermediate modality is near-infrared
branding (NIRB). Prior to CT, a pulsed, near-infrared laser is
used to create defined 3D marks in the fixed tissue that can
be traced by both FM and EM, and hence facilitates dissecting
the sample to assess the ROI in a biopsy. In Karreman et al.
[80], the position of the ROI was predicted with an accuracy of
below 5 µm.
A typical correlation workflow for a CMI pipeline including
for example, in-vivo optical microscopy, CT and EM typically
might include the following steps, and will need to be adapted for
the specific biomedical research question: (1) in-vivo functional
imaging of molecular dynamics using FM, such as spinning
disk, light sheet or multi-photon microscopy, or in-vivo imaging
of metabolic processes using advanced preclinical imaging
technologies, such MRI or OCT; (2) (a) near-infrared branding,
sample fixation, dissection, and further EM processing or (b)
dissection, high pressure freezing, and freeze substitution; (3)
resin embedding (lowicryl if fluorescence is to be preserved); (4)
CT for identification of ROI; (5) volume EM. This workflowmust
be adapted according to the desired biomedical outcome. To
preserve the native ultrastructure, cryo-fixation (high-pressure
freezing) might be desired. This might be followed either by
freeze substitution or by a cryo-workflowwith the aim to perform
cryo-EM. Surely, preserving the fluorescence (either with LR-
white or HM20 acrylic resins and adapted EM protocols or by
keeping the sample under cryo-conditions) can be of advantage
to re-locate ROIs. If considering serial section EM (or on-section
CLEM), fiducial markers can be added, and a commercial CLEM
system can be used to re-identify the ROI in the fluorescence
channel and retrieve it in the EM using e.g., SerialEM.
Several workflows have so far been established that solved
the above-mentioned challenges on sample preparation, re-
localization of ROIs, and data correlation. Recent examples
for multiscale combinations of in-vivo and ex-vivo imaging
include the correlation of intravital microscopy, CT and EM
to study single tumor cells in the cerebral vasculature [81];
correlation of X-ray holographic nano-tomography, EM and
FM to disentangle dense neuronal circuitry in Drosophila
melanogaster and mammalian central and peripheral nervous
tissue [82]; correlation of local neuronal and capillary responses
by two-photon microscopy with mesoscopic responses detected
by ultrasound (US) and BOLD-fMRI [83]; or extended
CMI pipelines that include the correlation of a variety of
imaging technologies, such as non-invasive US, CT and high-
resolution episcopic microscopy (HREM) for phenotyping
left/right asymmetries of all visceral organs in a mouse model of
heterotaxy or combined OCT, PAI and HREM of chick embryos
at multiple development stages [8, 84, 85]. Further examples
of novel CMI pipelines that uncover biophysical or chemical
information include the correlation of FM, molecular (MALDI
MSI) and elemental imaging [X-ray fluorescence (XRF)] to
analyze lipids and elements relevant to bone structures in the
very same sample section of a chicken phalanx without tissue
decalcification at the µm scales [86].
Correlation Software
In addition to the experimental elements helping to bridge
the different modalities mentioned in the previous sections,
analyzing automated software solutions to correlate complex,
multiscale, multimodal and volumetric image data including
reconstruction, segmentation, and visualization are an essential
pillar of CMI. Image processing and image analysis in biomedical
imaging is a wide field of research, having their own conferences
(such as ISBI, MICCAI, or NEUBIAS) and specialized journals
(IEEE TMI or Medical Image Analysis for example), with
thousands of new methods published every year. One common
aspect defining the field is the cross expertise needed to develop
new algorithms and software: The physics of the imaging
modality, and the knowledge of the biological model or of
the disease and organs beyond studies are usually important
elements to be considered when developing an image processing
or analysis method, making this field highly pluridisciplinary.
Methods tackle different problems such as restoration (denoising
and enhancing the quality and resolution of the acquired images),
segmentation (identifying and spatially localizing objects in
images), registration (aligning different images of the same or
similar objects), and visualization (generating a comprehensive,
potentially interactive, representation of the acquired imaging
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data). In this review, we focus on the two latter, in the context
of CMI. Other main elements are mostly specific to one modality
andwe refer the reader to existing reviews for general approaches,
for example, for the use of deep learning for all of these main
components of image analysis [87] or for specific components for
a specific modality (such as for EM image data restoration [88]).
Note that one exception can be made regarding segmentation,
where aligned volume can be sometimes used for what is called
multimodal segmentation where information gathered from the
different modalities refine the segmentation of the ROI [89]. This
last category is actually one example of the interest of CMI from
the image analysis point of view, where CMI helps image analysis
and quantification.
Image (2D or 3D) registration is the process of computing
the transformation linking two images or volumes to overlay
matching structures (Figure 5). It is a prerequisite for joint
quantitative evaluation of the data across modalities and scales
for any kind of multimodal visualization of imaging data.
The model of transformation, i.e., the number of degrees of
freedom allowed between the two images, is an important choice,
relying on the knowledge of the physical relationship between the
sample or the organ from one modality to the other modality.
This transformation can be seen as a change of coordinate
system if the organ or sample was not undergoing important
deformation or deterioration between the two modalities. In that
case, a rigid (rotations and translations), similarity (rigid plus
uniform scaling), or affine (similarity plus shearing or reflection)
may be sufficient. If there are deformations due to the sample
evolution over time or due to the sample preparation step for
the second modality, a more complex model allowing global
and/or local deformation will have to be used (non-rigid or
elastic models), according to the required accuracy. Currently,
registration is often done in a semi-automated way in two steps:
first, manual or automatic identification of landmarks or whole
structures (segmentation) in the images to be correlated; second,
manual definition of corresponding pairs of these features by
the user. These landmarks serve then as an input to the
registration process, that is computing an optimal transformation
by maximizing the spatial matching of all defined features pairs.
In CLEM, mainly three software solutions are used to perform
landmark- or segmentation-based registration: a plugin for FIJI
[90] (distribution of ImageJ including many useful plugins)
called BigWarp (initially developed to provide training and
validation sets), a plugin for ICY called ec-CLEM [91], and the
FIGURE 5 | Transformations and coordinate systems involved in the merging and visualization of multimodal data. All transformations between pair of images can be
then combined to link all acquisitions and move between scales and modalities. CoS means Coordinate System. T (CoSUS to CoSCT) means the transformation
spatially linking the two CoS, allowing for example to locate a US image in the CT volume. To compute the cell in the CT CoS, one can then combine transformations
and apply it to the fluorescent cell images (CoSFluo) for example T (CoSFluo to CoSCT) = inverse [T (CoSHisto to CoSFluo)] × T (CoSHisto to CoSµCT) × T (CosµCT
to CoSCT). Note that these changes of the coordinate system (or transformations) have to be computed in 3D to take into account possible changes of obliquity, and
that they do not take into account deformations induced by sample preparation from one imaging modality to another one.
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commercial software AMIRA (Thermofisher, Bordeaux France).
Several structures have been used to correlate, including vessel,
mitochondria, nuclei, added fiducials such as quantum dots
(QDs) in the correlative microscopy field, or specific anatomical
landmarks in the medical fields. Several other solutions exist
in particular in the medical field, but are very dependent of
the medical or biological question and of the workflow of
imaging. One method will usually be composed based on a set of
existing basic bricks performing one task to achieve the expected
results [92].
The challenges in fully automated multimodal registration
come from the discrepancy in the appearance of structures
by different contrast mechanisms and resolution. While the
specimen or sample undergoing imaging is usually kept the
same size, imaging can focus on a very different field of view
with a very different resolution. Algorithms then have to deal
with what is called occlusion effect. The problem is usually
tackled in a two-step process: first finding the coarse relationship
between images, then doing a more accurate registration, that
may take into account local deformation if any [93]. These local
deformations are usually due to the sample preparation step (for
instance, dehydration in histology, which makes the workflow of
Figure 5 very challenging without the use of fiducials). Twomain
approaches can be considered [94]:
(1) Considering the full content of the images and trying
to find a common representation intensity space to be
able to use monomodal approaches and metrics, or to
define a metric that would take into account the possible
discrepancy (a classical one is calledmutual information, and
is comparing joint histogram rather than intensity itself).
These approaches are preferred when the differentmodalities
present potentially similar content but with different aspects,
for example, when matching bright field imaging with low
magnification electronic images [95–97], when cell or nuclei
edges are visible on both modalities, or CT with MRI where
most of the anatomical structure will be appearing. An
interesting approach in deep learning, rather than learning
the common space between images, is to directly learn
the transformation parameters linking two modalities by
using pre-registered images undergoing a set of different
parameters for one given transformation as a training
set [98].
(2) Considering elements of interest extracted from both
modalities, for example anatomical landmarks (points or
shape of interest) or multimodal markers visible in both
modalities (such as fluorescent QDs in CLEM). These
approaches, generally called feature-based registration, are
of particular interest when the relation between content
is unknown or cannot be taken as an assumption (for
example for the validation of a new probe or a new
imaging modality). The method to find the matching and
compute the transformation can be done with two main
paradigms: transforming the image data in localizations with
potential additional features using point-based registration
([89, 91] for the AutoFINDER part of ec-clem) or
shape-based registration, potentially with intensity-based
machine learning approaches [99]. Note that a plethora
of variants exists for point-cloud registration, some of
them sounding particularly promising for feature-based
multimodal registration [100]. Interesting approaches mixed
both feature-based and full registration by restraining the
learning data set to registered features [101].
For both approaches one of the commonly used libraries for
software implementation is ITK (https://itk.org) usually coupled
with its visualization counterpart VTK (https://vtk.org).
Very powerful (command line) tools for landmark based
or fully automatic image registration (rigid and deformable)
are Elastix (http://elastix.isi.uu.nl), its derivative Simple
Elastix (http://simpleelastix.github.io) and ANTs (http://
picsl.upenn.edu/software/ants/). They allow the definition
of fully parameterizable complex registration pipelines.
Both libraries support the creation of so-called templates-
standard reference spaces that enable the co-registration,
comparison and joint analysis of images related to the same
structure as represented on the template. These images can
come either from the same or different subjects and, as
long as there is enough joint information content to ensure
registration, they can come from another modality. Multi-
channel imaging, where one channel enables easy registration
to the template, can support the integration of imaging data
with complementary information to the template, like the
integration of anatomical and functional images or spatial
gene expression data. One prominent example for such
standard spaces are standard brain templates that are used
to spatially integrate collections of multi-modal brain data
e.g., of humans or rodents like the Allen Brain (https://
portal.brain-map.org/) or Human Brain Project (https://
ebrains.eu) atlases, or the brain of adult [102] and larval [103]
drosophila melanogaster.
Visualizing multimodal data, also referred as image fusion,
require the knowledge of the spatial transformation linking
the images, obtained by registration as explained above. Once
this spatial relationship is known, there are several ways to
fuse the image information for its interpretation by the user
(Figure 6). Visualization per se is mainly categorized in two
areas: image and volume rendering (for example using ray-
casting algorithms), and region of interest rendering, using
for example surface representation with meshes of polygons
to match the ROI outside, after segmentation. One simple
surface representation without proper identification is isosurface
rendering, where a surface shape is defined by an intensity
threshold and a surface mesh generated from it. A third way is to
use slicing from a 3D volume and come back to a 2D visualization
problem. One of the difficulties in multimodal visualization is
the difference of spatial resolution between images, calling for
interpolation, e.g., upsampling the images of the modalities with
lower resolution to the same resolution as the images with the
highest resolution. Most registration algorithms automatically
resample the moving image to the resolution of the images
to which it is registered (the fixed or target image), meaning
pixels not existing in the original image have been created
by interpolation.
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FIGURE 6 | Example of image sources (volume rendering or segmentation) from different modalities, where each type of modalities will be processed differently to
provide the final visualization. Figure extracted from Schlachter et al. [104] under the Creative Commons Attribution License.
Efficient visualization of multimodal images will usually
propose a combination of different visualization methods [104]
and can add an additional channel of information related to the
registration itself, such as the error in registration [105, 106].
One of the particular challenges is to deal with data that do
not have the same dimensionality, such as time lapse vs. 3D or
hyperspectral images, and heterogenous data [107]. To keep the
full resolution of the biggest image, with data that can reach
several terabytes in size for just one specimen, efforts are ongoing
regarding efficient approaches of displaying and manipulating
very big data, such as the big data viewer [108] as also used in
the BigWarp Fiji Plugin.
For a more exhaustive list of software used in the field, the
reader is invited to refer to a constantly updated list of software
established in collaboration between the COST actions NEUBIAS
(CA15124) and COMULIS (CA17121): www.comulis.eu & www.
biii.eu.
CHALLENGES OF THE FIELD AND
CURRENT SOLUTIONS
Standardization
CLEM and Correlative Microscopy
As highlighted earlier, every biological question demands its own
technological approach. This makes standardization difficult.
There will never be one workflow to tackle every single question.
It is important however, to try to avoid re-inventing the wheel all
over again. Dissemination of established protocols and training
the next generation of scientists in these protocols is therefore
of the utmost importance. COMULIS is actively promoting such
training and standardization where possible.
In CLEM, one of the areas where standardization would
be possible is on the correlation precision. Where correlation
down to around 50 nm is currently possible (e.g., [16]), for
certain approaches an even more precise correlation would
open up completely new possibilities. Can we map single
fluorophores onto a single protein structure inside a crowded
cellular environment? This is currently a dream scenario but
will likely be possible in the future (see section CLEM and
Correlative Microscopy).
For the moment we will have to do with internal or external
added markers that can be used as fiducials for the alignment of
the two datasets. If these dual-modality markers are used also to
label specific proteins of interest, the first choice are quantum
dots as they are fluorescent and their core, generally being
made of Cadmium and Selenium, and is made of heavy metals
for visualization in EM. Care must be taken however that the
proteins coupled to such probes still fulfill its original function.
We have shown that Transferrin coupled to QDs does not recycle
anymore but, likely due to multiple receptors binding to one QD,
is directed down the degradative pathway [109]. An alternative
approach, using fluorescent moieties coupled next to a gold
particle, has its own issues. It is well-known that fluorescent dyes
can be quenched when in close proximity of gold particles [110].
We have recently shown that Alexafluor488 coupled to a 10 nm
gold particle is quenched by 95% [111] rendering that particular
probe useless as a true CLEM probe. One is probably better off
using two individual probes, one tagged with fluorescence and
one tagged with gold particles. In our experience a 1:10 ratio
works well. Due to technical restraints we have not been able to
measure the quenching effect of smaller gold particles yet. One
can also add a fiducial marker from the outside. Kukulski et al.
[16, 18] reported the use of 50 and 100 nm sized fluorescent beads
that are added just before fixation and which are also readily
identifiable in the electronmicroscope. The current methodology
allows to correlate the LM and EM images from such experiments
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down to approximately 50 nm and would at the moment be
considered as the standard. With the increasing integration of
super-resolution FM technologies into CLEM workflows, this
precision is most likely to improve. This does however warrant a
remark. Again, it is all down to the underlying question what kind
of precision is required. When one is for instance searching for a
rare transfected cell amongst a field of untransfected cells all that
is required is a correlation precision in the range of micrometers
rather than nanometers.
In correlative AFM, first combinations studied the sample
first using FM and then transferred it to the AFM [112], which
restricted correlation. Early efforts imaged the fluorescence
of labeled molecules and topographically imaged the same
area. This was misleadingly termed as synchronized operation.
The two high-resolution techniques can hardly operate
simultaneously due to their reciprocal disturbances. Apart
from the mechanical instability of the construction, FM
excitation laser(s) can induce disturbances by influencing the
detection system of the AFM and/or by short-time heating of
the cantilever. Additionally, the AFM laser can lead to photo-
bleaching of fluorescently labeled molecules. In general, these
problems can be solved by carefully planning the performed
experiments and adequately assembling the correlative setup.
The biological material itself and the molecule of interest has to
be immobile or immobilized as otherwise we would not be able
to benefit from the merge. Most immobile samples are studied
in combination of AFM with superresolution as both techniques
demand immobile samples. Optical microscopy allows studying
molecules within transparent samples in contrast to AFM, which
is exclusively applicable on surfaces. TIRF excites fluorophores
only close to an interface between different optical densities. To
limit the influence of the optical excitation to the AFM system, it
is convenient to combine these two methods.
Preclinical Hybrid Imaging
Over the last decade, there has been an ongoing discussion
about the ability to successfully translate preclinical findings into
clinical practice [113–116]. Multiple studies have demonstrated
that a bench-to-bedside translation from preclinical results
into clinical practice is not as easy as anticipated [113, 115,
117]. Figure 7 illustrates multiple biological, methodologic
and technical factors inherently linked to the reproducibility,
reliability, and comparability of preclinical imaging data. Each
of these factors has a significant impact on the validity of
the acquired data and hence can influence reproducibility and
reliability of results. Furthermore, it has been shown that
replication of already published results is not as straightforward
as the scientific community would hope [113, 119, 120]. Hence,
standardization of preclinical imaging protocols and techniques
to overcome the “replication crisis” has been stated to be of
utmost interest [121, 122].
In sharp comparison to the preclinical research field, clinical
standardization is much further advanced and accreditation
programs of scanners have been implemented together with
unified quality control protocols to ensure reliable, comparable
and reproducible results. Furthermore, standardized protocols
are in place, which allow multi-center comparison and pooling
of the data [123–125]. However, multi-center comparison is
still not as easy as anticipated, but up to this point the efforts
undertaken have clearly shown its benefit in clinical practice
[126, 127].
It is important to emphasize that “over”- standardization in
the preclinical environment is not the goal. The fast, dynamic
pace of preclinical development is still a strength of one of
its kind and should not be outmaneuvered. However, we have
to ensure that preclinical findings can be translated more
straightforward into clinical research and practice. Therefore,
certain techniques, such as anesthesia protocols and animal
handling, need to be unified. Furthermore, as has been stated
multiple times, precise reporting of methods and techniques
is of utmost importance to ensure feasible replication, as well
as to facilitate findings from literature and build up based
on the existing knowledge [128, 129]. Guidelines, such as the
“Animals in Research: Reporting in vivo Experiments (ARRIVE)”
guidelines help to improve the quality of reporting, and will
consequently maximize the output and validity of published
data [129]. In addition, multiple journals have updated their
requirements for manuscript submission so that the respective
authors either need to upload imaging data as well as all
metadata, or to include a data availability statement during
submission [130, 131]. An open access of the imaging data and
respective metadata is certainly a huge step toward transparency
and increased reproducibility and reliability of the data [132],
as it has been demonstrated that image analysis is highly
user- and software-dependent [133]. Randomized preclinical
multi-center studies have been proposed to overcome the
lack of reproducibility due to inadequate sample size, low
significance, and low confidence of data [134–137]. However,
the potential of multi-center studies cannot be fully accessed
without proper standardization techniques in place in each
participating institute. A recent study focusing on utilizing a
basic [18F]fluorodeoxyglucose ([18F]FDG) imaging protocol in
4 different institutes demonstrated that the comparability among
multiple institutes might be hampered due to, e.g., animal
handling (each institute had different fasting protocols of animals
in place; temperature regulation of animals during acquisition
differed significantly), and animal facility environment or image
analysis [133].
In regards to image analysis, the use of hybrid imaging
technologies, with which anatomical co-registration data can be
acquired using CT or MRI, significantly enhances the reliability
of image analysis since this allows a precise definition of
ROIs on the anatomical images that can be overlaid with
functional imaging data (e.g., PET or OI data) to ensure the
correct placement of ROIs, which is often difficult on functional
data only [133]. Multimodal hybrid imaging can enhance
reproducibility of results, but nevertheless precise standardized
protocols to do so need to be implemented.
There is a huge demand for standardization in preclinical
imaging and efforts to implement standardized protocols
undertaken by initiatives, such as COMULIS, on a multi-center
basis are certainly major steps toward more reproducibility
and reliability of preclinical imaging data, as well as increased
translation into clinical research and practice.
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Correlation Software
As seen from section Correlation Software, different methods
have already been proposed in the literature for image
registration or multimodal visualization. However, a few of
them are actually used by researchers in life sciences, and
one of the main reasons for this is the lack of user-friendly
implementation and availability as software. In addition, as
underlined in the other sections, every biological or medical
questions comes with its own image analysis workflow [92]. In
order to help with these workflows, but also to help data sharing
and open science, a standardization of the representation of
the multimodal spatial relationship and content types will be
important. In the medical imaging field, such standards are in
place, using Digital imaging and communications in medicine
(DICOM), which includes guidelines for the representation of
spatial transformation betweenmultimodal images [linear (C20.2
DICOM) or deformable (C 20.3 DICOM)]. However, the list
of metadata proposed by DICOM is really exhaustive and may
prevent users and constructors to actually fill in this information,
which represents 15% of major errors as reported in Gueld
et al. [138]. In particular, this effort will be important for
imaging modalities for which this standard is not in use now
and information is not automatically filled in, or for third-
party software or home-made methods to compute the spatial
transformation that link two images or volumes. For this reason,
there is ongoing effort associated with the deployment of public
image archive [139–141] to define some minimal metadata
requirement, and the one associated with CMI have still to be
defined by the community.
Computing the accuracy and assessing the quality of the
registration is one of the central problems of correlative
microscopies or more generally CMI, in particular because the
structure of interest is usually not marked in both modalities,
and so it is essential to confirm the correlation is correct and
not biased by user assumptions. This is of particular importance
when dealing with largely multiscale approaches, since one
pixel can be matched with a structure of hundreds of pixels in
another modality, and then an error of one pixel could lead to
erroneous conclusions. In previous publications [16, 142], an
iterative leave-one-out method was used to assess the accuracy
of the registration, where the registration error was computed
as the average error of localization of beads not used for the
registration and was therefore empirical. Recent work tried to
find a theoretical estimation of the error, using the Cramer
FIGURE 7 | Biological, chemical, methodological and technical factors inherently linked to the reproducibility, reliability and comparability of preclinical imaging data.
Figure adapted from Figure 1 from Herfert et al. [118] with reprint permission from Springer according to their creative common license http://creativecommons.org/
licenses/by/4.0/.
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Rao limits [143] to estimate the transform error by taking into
account the high resolution limit of accuracy. In ec-clem, the
error is estimated using a formalism from themedical field for 2D
and 3D rigid registration [144], originally developed for image
guided surgery. It can be applied to correlative microscopy but
is limited to a rigid-transformation point-based framework, and
has the advantage of not requiring any ground truth matching
in the images. In addition, this method may lack a proper
mathematical formalism to demonstrate their usability in the
fields. Note that metrics to compare images based on intensity
may not be adapted in most of the case due to the discrepancy of
image content (structures not present in both images). In the case
of the absence of fiducials or anatomical landmarks to validate
the registration, another currently used method to validate the
accuracy of a registration is to use segmentation quality metrics,
such as DICE metrics, to assess the overlap between known
segmented structure.
Challenges are the competition of algorithms on a given
dataset, where the ground truth is known in order to rank
the algorithms according to a set of metrics designed for
the challenge. Some challenges have been organized for the
multimodal field, but usually focused on one particular problem
(Anhir focused on multiplexed histological data or Curious for
US to MRI brain images registration [145]). These challenges
are of great interest since they provide a way to identify the
actual level of accuracy state of the art and give direction
for future research. They will also help define common
and standard ways to assess the accuracy of the alignment
of multimodal data, by defining community accepted stand
error metrics.
Requirements for Optimization and
Challenges to the Field
CLEM and Correlative Microscopy
In the recently published book “Correlative Imaging: Focusing
on the Future,” there was one over-arching theme that was
highlighted in almost all chapters: Data. If handling data
from a single modality can already create headaches for the
data analysis and IT people, how about trying to combine
datasets from different imaging modalities. Developments
and possible solutions will be discussed in other parts of
this review.
On the hardware side there are also clear trends visible and
they almost seem to diverge from each other. On the one hand,
there are the cryo-CLEM approaches trying to map protein
structures in ultrastructural data, on the other, volume CLEM
(a collection of techniques including FIB-SEM, SBF-SEM, array
tomography, electron tomography) is more focused on large scale
structures and mainly looks at connectivity between cells.
As with the integration of GFP in CLEM from 2000, the
resolution revolution in cryoEM has now also been integrated
into CLEM workflows, especially aided by the development of
LM stages that can work under Liquid Nitrogen conditions [146–
148]. These devices allow for the observation of fluorescent
structures of plunge frozen samples and record their location
for further studying in a cryo-TEM. Whereas, these stages
are now fairly commonly in use, the development of cryo-
CLEM workflows is still improving; e.g., super-resolution cryo-
fluorescence has been recently shown [149]. One of the issues
that needs to be dealt with in cellular cryoEM is the thickness
of the sample. In most cases, only the outer edges of a cell can be
directly imaged. Anything more inside will be too thick to image
directly. Cryo-FIB-milling is currently the only way to acquire
thin slices of frozen material for cryo-electron tomography (ET)
[150]. Targeting the correct area in Z-height, the depth of the
sample, is still one of the bottlenecks but acquiring fluorescence
data in 3D using confocal cryo-fluorescence will further aid with
this targeting problem.
Life is 3D, so also techniques falling under the quiet
revolution banner (FIB-SEM, SBF-SEM, Array tomography,
electron tomography) are being integrated more and more into
CLEM approaches. Especially in these cases, finding the structure
of interest adds another dimension of complexity. Resolution in
z is generally lower than in x, y so targeting is even more difficult.
Also acquisition of z-stacks acquired before processing for EM
can be useful and essential but the coordinates may change
during the processing. The addition of fiducials or endogenous
tissue-existing landmarks, such as blood vessels, can be useful. In
addition, a bridging step with intermediate resolution such as CT
are relatively new additions to the CLEM workflows [80].
Fully integrated light and electron microscopes should be able
to provide the best correlation between the two modalities and
both integrated LM-TEM [151] and LM-SEM [111, 152] have
been developed and are still improving. Of note here is that all
these systems can only work with fixed samples and one of the
hallmarks of light microscopy, live imaging, is lost. As before, it
is the biological question that will determine what workflow and
technology fits best.
In correlative AFM, correlative challenges and opportunities
are faced by recent technological advancements, improving
temporal and spatial resolution of already established techniques.
The combination of these highly sophisticated setups is far
from trivial and highly challenging. High-Speed Atomic Force
Microscope, for example, allows studying dynamic processes at
sub-molecular and sub-second scale and can be combined with
STED to track molecular movement at nanometer resolution and
in the millisecond range.
To enable a precise and simultaneous superposition,
disturbances in correlative AFM must be sufficiently shielded.
An acoustically shielded chamber around the FM including
the AFM measuring head is suitable for this purpose. All
components that can cause electronic or acoustic interference
must be removed from the isolation chamber. Typically,
water-cooled EM-CCD cameras are used here to minimize
interference from the outset. During simultaneous applications,
the problem arises that the measuring tip of the AFM is heated
by the excitation laser. This problem cannot be prevented; in
this case, combinations with TIRF or confocal microscopy are
usually used. It is important to keep the excitation energy at
the position of the cantilever low. If both techniques are used
at the same time, a real time superposition of the images is
currently not possible. In most cases, the images have to be
adapted to each other by mathematically forced imaging errors.
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For this purpose, a fluorescent grid is suitable which is taken
before the actual measurement with both techniques at the same
position and subsequently adapted to each other. Currently,
the AFM manufacturers already offer their own software for
superimposing the images. The measuring tip is moved to
several different positions, which are recorded simultaneously on
the microscope and then superimposed directly. However, the
measuring tip in the fluorescence image cannot be superimposed
more precisely than the resolution of the microscope. Of course,
the resolution can be increased by fitting techniques, known
from super-resolution microscopy, but the resolution of the
AFM itself can never be achieved.
Further challenges will be the combination and further
development of additional microscopy technologies, such as
correlative SXT. Since imaging under cryo-conditions preserves
a close-to-native environment (as for cryoEM) and in certain
cases (as for SXT due to its operation in the water window) is
the only possible implementation, the development of cryo-FM
will play a crucial role in correlative microscopy. For correlative
SXT, superresolution FM is specifically appealing since it matches
the achievable spatial resolution, and further efforts will focus on
its cryo-implementation [23].
Preclinical Hybrid Imaging
One of the current bottlenecks for PHI lays in radiation doses
for X-ray imaging together with radioisotopic imaging methods.
CT, PET, and SPECT imaging delivers substantial radiation
dose into the animal, and, of course, to the patient as well
in clinics. The prolonged CT scanning times along with high
doses of radioisotopes applied to the animal may interfere with
the immune system, tumor growth and rapidly proliferating
tissues (bonemarrow, intestine) renewal. There are estimates that
up to one percent of patients repeatedly scanned for possible
metastases by whole body CT, PET/CT or SPECT/CT during
a 5-years follow-up period may die because of new tumors
induced by the imaging process [153, 154]. The significantly
lower radiation load to the patient brings PET/MRI imaging;
nevertheless, the high dose coming from high energy PET isotope
injection cannot be avoided. Moreover, CT is excellent for hard
tissue (bone) and contrast (e.g., angiography) imaging but soft
tissue discrimination is rather poor. Several companies brought
to the market so called spectral CT devices. They are usually
based on dual energy X-ray sources, and the comparison of the
energy-dependent attenuation of signal can improve the soft
tissue recognition and distinguish contrasts and the bone, which
is not possible in classical CT devices [155]. These CT machines
can utilize slightly lower radiation dose compared to previous
generation. Due to the recent progress in the development
of novel radiation detectors, there occurred a possibility to
introduce a completely new radiation detection approach. Under
international collaboration in CERN, the photon counting
TimePix detectors were developed. The current generation of
TimePix3 detectors allows a simultaneous detection of the exact
position, energy and time of the photon interaction. These
properties can be used for true spectral CT detection. Novel
detectors are much more sensitive and have a high spatial
resolution of 55µm. The CT image can be obtained very fast (in
seconds compared to 20 to 30min for high-resolution standard
scans), thus significantly reducing the absorbed radiation dose.
The filtering of noise allows to increase the signal-to-noise ratio.
According to different attenuation tissue patterns, soft tissue
recognition is easier even without contrast [156]. The high speed
of TimePix3 detectors (1,700 images per second) and energy
resolution is suitable for coincident event registration also in
PET imaging [157]. The proof-of-principle of the use of the
TimePix3 detectors has been published [158]. Several groups
are testing the use of Compton cameras for SPECT imaging
instead of collimated SPECT detection [159, 160]. Compton
cameras allow to calculate the trajectory of incoming photons
from original hit position and Compton scattering detected by
a second detector layer. This allows to increase the sensitivity
of SPECT from <0.1 to 80% for the most used SPECT isotope
99mTc. SPECT imaging thus only requires a fraction of currently
used radiation activity, and the absence of collimator facilitates
the construction of combined CT/PET/SPECT devices with just
one ring of detectors that can simultaneously record fast fully
trimodal hybrid whole body imaging with very low radiation
load. The main limitation is still the high price of detectors
which could be in future substantially lowered by demand for
production in large series.
Most of the optical imagers allow to detect fluorophores from
visible light up to the NIR region with the longest wavelengths
around 850 to 900 nm. This covers the close NIR region with
relatively good light penetration. The signal loss in deeper tissues
does not permit quantitative data nor fully tomographic imaging.
Mouse tissues are much more transparent for shortwave infrared
light (SWIR) with wavelengths between 1,000 and 2,000m. No
autofluorescence, reduced light scattering and lack of absorption
by blood are the main advantages of imaging in the SWIR region
[161]. The first commercial in vivo optical scanner allowing
imaging of contrasts with longer excitation wavelengths than
1,000 nm appeared on the market in 2019. The method is still
limited by the low availability of fluorescent contrast agents for
use in the SWIR region.
Besides, there is the current challenge of correlating additional
beneficial but not yet readily/commercially available imaging
modalities (same challenge as faced by the biological microscopy
community). For example, while fusion of optical tomography
data (DLIT, FLIT, or FMT) with CT can be achieved using
commercial imaging systems, co-registration of OI and MRI
is still in the developmental state. As OI and MRI are
recorded in separate systems, relocations of animals between the
recording sessions have to be conducted with great diligence
to avoid anatomical distortion and positional changes. Chehade
developed a shuttle made of CT- and MRI- compatible material,
which allowed the relocations of mice while keeping them
properly in place [77].
These challenges hold also true for in-vivo microscopy—
despite its impressive advances. It is still challenging to
synergistically combine optical technologies in one platform
since they do not match in imaging speed, size, resolution and
contrast, and proper imaging pipelines have to be established.
In this context, CMI platforms for label-free sample screening
bear great potential, and working combinations of these
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modalities (such as OCT, RS, MPM, SHG—STATE-OF-THE-
ART/Preclinical Hybrid Imaging) will need to be identified on
the basis of their added value in tackling specific biomedical
research questions.
Novel CMI Pipelines
Novel CMI pipelines will continue to bridge in-vivo (preclinical)
and ex-vivo (biological) imaging and allow to zoom in from
physiological native tissue context to subcellular molecular
resolution. This comes with several challenges to be tackled:
(1) sample preparation that is compatible across imaging
modalities without compromising data quality, (2) hard- and
software solutions to relocate the same ROI after changing the
imaging platform, (3) robust markers that can be detected in
different imaging technologies, (4) lack of high throughput and
automatization, (5) software solutions to correlate the imaging
data and standards for data handling and storage, (6) availability
of research infrastructure (i.e., cutting-edge imaging technologies
from PET scanners down to cryo-EM).
(1) Sample preparation procedures are mainly an issue across
ex-vivo imaging technologies since these require specific
fixation and embedding that might be incompatible
with other techniques. Typically, most in-vivo imaging
protocols such as MRI, CT or US do not interfere with
downstream processing for histologic and ultrastructural
observation. This is true even when routine contrast agents
are administered for in-vivo imaging. Typical example
of incompatibility are the quenching of fluorophores
by standard EM preparation protocols (compare section
CLEM and Correlative Microscopy) or incompatibility of
glutaraldehyde fixation or JB4 resin embedding with many
protocols for immunohistochemistry. In general, fixation is
a critical parameter in correlative workflows and requires
optimization since it usually comes with sample-distorting
artifacts, such as tissue shrinkage, swelling, hardening, and
color change. Besides, it is of highest importance to fix
the tissue or organism right after euthanasia to prevent
autolysis and degradation of cellular structures [162]. To
improve the penetration of fixatives, the tissue or sample
might need to be incised. The sample should then be
incubated in at least 20 times the sample volume, and,
to facilitate correlation, be pre-embedded in 1% agarose
using a casting mold prior to processing [163]. Ideally, both
macroscopic and microscopic morphologies are preserved
by the simultaneous stabilization of all cellular components
as achieved by cryofixation. However, while preserving the
close-to-native morphology, the drawback of cryofixation in
comparison to chemical fixation is its limited depth to which
samples can be well-frozen. High-pressure freezing allows
to fix a thickness of maximally 0.6mm. Continuing to work
under cryo-conditions ensures close-to-native architecture,
but poses additional challenges to potential follow-up
microscopy technologies such as FM—since current cryo-
objectives are limited in their optical performance (such as
low numerical aperture) [164].
Importantly, all destructive staining needs to be avoided:
An example is the perfusion of vasculature with heparin,
formalin, NaCl and barium sulfate with gelatin to stain blood
vessels via the ventricles after anesthesia in mice. Vasculature
staining can be replaced in certain cases by post-mortem
staining with Lugol’s solution, a mixture of one part iodine
and two parts potassium iodide in water [165].
Imaging thick tissues or entire organisms in vivo
and subsequently zooming-in into the subcellular
ultrastructure is facilitated by current advances in FM
of non-transparent organisms, such as longer wavelengths
for deeper penetrations depths [166], development of
improved near-infrared probes [167], or photoacoustics
[168]. While studying even thicker tissue—though in-vitro—
will be facilitated by further advancements in clearing larger
samples using lipid extraction to reduce light scattering, it
is questionable whether this will also facilitate correlative
microscopy approaches since clearance of larger samples
might interfere with ultrastructural preservation.
(2) Identifying the same ROI across diverse in- and ex-vivo
imaging platforms is currently an inherent bottleneck of
novel CMI approaches. Specifically, the relocation of a
ROI in thick living tissue at high subcellular or molecular
resolution presents the biggest challenge faced by CMI when
bridging in-vivo preclinical imaging and ex-vivo biological
microscopy. As outlined in 2.3, current strategies focus
on NIRB as an intermediate step for volume CLEM.
If no additional processing step is foreseen between
modalities (which might induce distortions or even require
reduction of the volume by sectioning), the straightforward
approach to correlate the ROI across modalities is to use
a joint transferable coordinating system. A well-established
example is the annotation of FM to define ROIs with a
dedicated CLEM module and import and relocate these
coordination lists into the cryo-EM microscope using
SerialEM [169]. Other approaches focus on using the same
holder for different imaging modalities. Examples include
immobilization beds for preclinical imaging in mice using
PET and CT (where additionally 22Na fiducial markers
can be placed into stationary pegs at defined depths to
provide a 3D references to simplify image registration), or
the combination of x-ray spectromicroscopy with electron
tomography, where Allende meteorite grains were deposited
on a TEM grid and transferred between the electron
microscope and the COSMIC soft x-ray beamline [170].
First “plug-and-play” holder solutions are being described
that are compatible and even commercially available, which
can fit in a variety of microscopes for correlative imaging
without changing the holder. While it facilitates relocation
of ROIs tremendously, this approach cannot overcome the
main limits or CMI pipelines: To assess a ROI in thick
tissue, the tissue will still need to be cut due to the
limited penetration depths of most high-resolution ex-vivo
microscopy techniques.
To facilitate ROI relocation, CMI also aims at setting
up hardware-fused hybrid setups that inherently co-localize
the same ROI due to their joint coordination system. Apart
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from well-known commercially available PHI scanners
(such as PET/CT, SPECT/CT, or PET/MRI), as described
in section State-of-the-Art, examples include (i) a variety
of hybrid AFM and FM setups [30, 171, 172], (ii) first
implementations of integrated EM-FM setups [111, 173],
(iii) several combined setups of OCT with photoacoustics
or non-linear microscopy [174], and (iv) diverse hardware-
based approaches to combine OI techniques with CT orMRI
[175]. Nevertheless, in certain cases, relocation across single
modality systems using cross-platform transport beds for
CMI may provide superior performance compared to hybrid
systems where compromises may have been made in the
integration process.
If hybrid setups are not available (as is mostly the
case), correlation can be facilitated by imaging the exact
same sample without intermediate processing steps. For
example, instead of performing FM before EM fixation and
embedding, EM sections could be imaged directly with FM if
preserving fluorescence or immunolabeling them.
(3) There is a plethora of multimodal probes for correlative
microscopy and preclinical imaging, but there are hardly any
robust markers that can be detected across modalities
when combining various contrast mechanism with
high microscopic accuracy. For correlative microscopy,
most commonly used markers include QDs or polymer
beads. Other examples include biocompatible nanosized,
fluorescent and electron-dense intracellular nanodiamonds
(internalized in living cells via endocytosis) as probes for 3D
CLEM [176]. For the combination of preclinical imaging
modalities, mainly CT, MRI, and optical approaches, there
is a variety of CMI probes: (1) Lipid-based markers, such as
liposomes or lipoproteins as carriers; (2) macromolecular
carriers where different contrast agents are attached to a
common macromolecule (and its reactive amines, thiols,
or carboxyls); (3) nanoparticles, such as QDs, iron oxide
nanoparticles or nanoparticle carriers; or (4) small molecules
where two or more probes are directly fused together with
minimal intervening bonds [177]. Further examples include
high-contrast, non-radioactive tungsten-based fiducial
markers for multimodal brain imaging with MRI, PET and
CT that are attached outside of the sample in close proximity
of the ROI, and numerous dual PET and NIR fluorescence
imaging probes [178, 179], such as fluorescence-labeled
monoclonal antibodies (mAbs) and systemic applications
of both mAbs and peptides in PET/SPECT in-vivo. While
64Cu the prevalent isotope for systemic mAb imaging, 18F
and 68Ga isotopes better match the targeting half-lives of
peptides. Although dual agents for PET and NIR imaging are
in its infancy and no agent has been approved by the FDA
so far, several preclinical applications have been reported
[179]. Examples for markers for advanced CMI pipelines
include photo- or chemically-convertible tags (such as
miniSOG or APEX) that can be detected in FM, CT and EM
and were used to identify the ROI across multiple imaging
modalities [180–182].
Most multimodal probes are exogenous. The ultimate
goal is to have the organism or cells express their own probes
after transfection. Fusions of GFP for fluorescence imaging
and herpes simplex virus thymidine kinase (HSV-TK) for
PET have been reported in several studies. HSV-TK can
also be fused to other optical reporters and constructs of
luciferase. With QDs and (NIR) fluorophores being used
across preclinical and biological imaging modalities, these
two markers appear most promising for advanced CMI
pipelines. While a single CMI marker will guarantee the
same pharmacokinetics and colocalization of the signal for
each modality and reduces the stress on the blood clearance
mechanisms of small animals (as induced by multiple doses
of agents), the variations of sensitivities of different imaging
modalities need to be considered when aiming for the
detection of a single probe correlatively. In certain cases, it
may not be practical to simply add all functionalities to one
molecule [177].
For a rough alignment of untreated samples between
relocation of imaging platforms, registration marks such as
gridded coverslips or finder grids [183], or deposition of
metal structures or engraving of the surface are commonly
used. To provide rough orientation when dissecting ROIs
from living organisms for subsequent ex-vivo analysis, the
margins of adjacent tissue are demarcated in their bodily
orientation with surgical ink or notches on the skin. For
advanced CMI pipelines from thick tissue to 2D sections,
endogenous landmarks or NIRB can be used. In volume
CLEM, blood vessels, nuclei or myelinated axons can be used
as endogenous fiducials since they show sufficient contrast
both in light and electron microscopy and are distinctive in
size and shape—as demonstrated for mouse brain imaging
using a CMI pipeline with in-vivo 2-photon microscopy and
FIB/SEM [6].
(4) Nanometer-resolution of the subcellular architecture of
tissues usually requires time-intensive scanning of the
sample (as for FIB/SEM or AFM) since lateral resolution
often comes at the expense of penetration depth and field
of view. The selection of a volume of interest several
orders of magnitude smaller than the sample imaged
by FM is hence both crucial and challenging. Solutions
to studying big volumes at high resolution and with
high throughput include the use of multi-beam setups
(such as multi-beam SEM [184]) with parallelized data
collection, or the automation of the identification of ROIs
and image acquisition [185]. Since advanced CMI setups
require tedious protocol optimization, time-intensive image
acquisitions and intermediate processing steps, in general,
novel CMI pipelines suffer from lack of throughput, which
restricts reproducibility and statistics. Currently, the focus of
CMI pipelines is rather on identifying working combinations
to address previously inaccessible biomedical research than
on fostering throughput. Once those correlations have
been showcased and are proven feasible by substantial
R&D efforts, CMI will enter further automatization and
simplification to generate throughput.
(5) Advances and current trends in correlation software are
discussed in sections Correlation Software and Correlation
Software. To expedite automated multimodal image
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registrations and quantification, data handling specific
to multimodality needs to be established, including
universal imaging formats, ontologies, and data storage
and repositories. While there is currently no universally
established microscopy format with additional diversity
between preclinical and biological imaging approaches,
repositories and public archives for diverse imaging data are
being implemented—from single molecules (EMPIAR) to
tissues (Tissue-IDR). Correlative data sets (such as CLEM
data to link functional information across spatial and
temporal scales) will be included in the so-called added-
value databases that are developed around the archive.
They aim at gathering a greater understanding for specific
biological areas through systematic integration of images
[141]. Integration of such multimodal data sets and their
interoperability will be facilitated by universal large-scale
multi-granular imaging ontologies, whose need is being
described in first publications [186, 187].
(6) Novel CMI pipelines require access to diverse imaging
technologies. All these technologies and the necessary
expertise are unlikely to be found in a single laboratory,
which restricts the development and implementation of
CMI. To facilitate access to complementary imaging
technologies and exchange of knowledge, several initiatives
have been established. Two prominent examples are
(1) COMULIS (Correlated Multimodal Imaging in Life
Sciences), a COST Action (CA17121) to foster CMI, and
(2) Euro-BioImaging, a European Research Infrastructure
Consortium providing open access to imaging technologies
in biological and biomedical research.
Correlation Software
As already underlined, most of the automated methods are
developed ad hoc for a particular multimodal problem. Machine
learning and deep learning are definitely moving the image
analysis field a step forward [87] since their main interest is
to create an ideal method of processing based on training data
sets, translating the effort of developing ad-hoc computer vision
or signal processing methods to the effort of annotating data
and formalizing the problem as input/output. Note that deep
learning is still in progress and a lot of research is still going on
to optimize these methods and reduce the number of training
datasets required, as well as taking into account the errors in
annotations in training data sets [87]. Based on these approaches,
a universal solution without any user input is not envisioned per
se, but rather a universal framework for multimodal registration,
or the creation of a giant bank of pretrained models. It could be
envisioned to be set up withminimal user input, i.e., by providing
registered data sets or at least identifying on both modalities
what should be used for matching. There are ongoing approaches
for a universal segmenting tool, based on deep learning, trained
on different data, for example, for nuclei segmentation [188].
Interestingly, it has been shown that some of the models trained
could be applied in a new different modality (even if all at the
same microscopic scale), for example, with different staining
without the need of further training.
Another challenge in the field is the integration of very
heterogeneous data, such as CMI with very different dimensions
(multiplexing or spectral data with hundreds of outputs for one
spatial localization, temporal vs. static) with non-imaging data
such as -omics data. This effort could be facilitated by two
approaches: the single cells approaches, and the development
of spatially localized proteomics or genomics which are now
starting to appear as commercial platform and would facilitate
these links. But then the analysis of this largely heterogeneous
data still requires to develop new statistical tools.
Another trend is to use multimodal aligned images as
training sets to construct inference models to reduce the
needs for one or the other modality. For example, Li et al.
[189] used a deep learning approach to generate PET images
from MRI and demonstrated similar classification results
using the generated PET images than the true PET images
for Alzheimer Disease and Mild Cognitive impairment. In
this preliminary study, a 3D convolutional neural network
was trained with MRI patches as input and matching PET
patches as output using half of a database of patients
having both exams. The parameters of the network capture
a relationship between both modalities. This trained network
was then used to generate the predicted PET images from
MRI images, and validated against the remaining half of
the database. The same principles have been applied also
to microscopy images, where for example restoration based
on deep learning have shown impressive results [190], and
even predicting fluorescent labeling from transmitted light
images [191].
These approaches in the long term could then reduce
the number of modalities required to answer a particular
question. To achieve such a goal, sharing well-annotated aligned
multimodal data is of particular importance. Efforts are on-going
in this direction to share repositories and public archives ([141],
Empiar, IDR).
CONCLUSIONS AND OUTLOOK: FUTURE
OF THE FIELD
To have an even bigger impact and to become a basic life science
technology as FM is nowadays, it will be crucial for correlative
microscopy to develop and disseminate automated workflows
that can deal with huge amounts of data and seamlessly merge
diverse data sets. This process will be facilitated by a number
of factors: the improved capabilities of integrated systems, the
adaption of standard file formats, and the deposition and sharing
of these information-rich datasets.
For PHI, preclinical molecular in-vivo whole-body imaging
is fully dependent on hybrid imaging and co-registration with
anatomical images. Some devices are already multimodal in
their hardware settings, but images from different techniques are
taken sequentially and implemented automated co-registration
often requires manual intervention to obtain the best results.
Multimodal animal beds allow to scan the same anesthetized
animal in different devices, co-register multiple imagingmethods
and obtain enhanced molecular information about the in-vivo
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processes. The implementation of new methods and contrast
agents broadens the spectrum of imaging possibilities, and
simultaneously acquired multiple hybrid images facilitate proper
visualization. Besides, OI has seen significant expansion in
biomedical and diagnostic applications, which go beyond simple
visualization of the sample. Novel modalities allow label-free
mapping of biomolecules in vivo providing a way to determine
a stage of disease progression or enable tomographic assessment
of deep tissue layers. Nevertheless, current research efforts
are indicating that in many biomedical applications, a single
modality is inadequate to provide a comprehensive picture of a
disease. Instead a targeted combination of modalities, which give
access to a set of (label-free) parameters is necessary.
In summary, CMI is a field under construction, relying on
broad expertise. In particular, data processing, analysis and
management need to be incorporated in the initial reflections
leading to a project, and a continuous and iterative dialog has
to take place during the whole project with image data analysts
such that the communities can understand the requirements
and needs of each other. Setting up standard approaches
and sharing protocols and generated data will definitely be
the key elements for achieving a smooth communication.
A real holistic view will be achieved when other type of
data will be also correlated with imaging data, but to reach
such a goal the CMI community needs to develop its own
solid ground.
Ideally, CMI will lead to multimodal platforms that allow
to functionally and morphologically characterize the entire
sample in-vivo, fast and non-destructively at high axial and
lateral resolution and high penetration to gain a mechanistic
understanding of organisms and diseases. By synergistically
fusing complementary imaging techniques, CMI platforms
can give insights into a variety of tissue properties during
a single image acquisition, and better tissue characterization
can be achieved than by the separate imaging modalities
alone. Complementary information provided by the fused
imaging modalities and machine-learning-assisted data analysis
will ultimately yield novel biomarkers by a multi-dimensional
classification accelerating the discovery and translation of
novel therapeutic strategies. Such hybrid platforms of high
accuracy will correlate the modalities instantly without the need
for post-processing correlation software. Surely, 3D cellular,
ultrastructural and molecular tissue maps as acquired by CMI
will substantially transform biomedical research and diagnostics
in the future.
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